The board of directors of The IBN Sina Pharmaceuticals Industry Ltd has recommended 30 per cent cash dividend for the year ended on June 30, 2019.
The AGM will be held on November 14. The record date is on October 14.
The company has also reported EPS of Tk 10.76, NAV per share of Tk 47.32 and NOCFPS of Tk 13.87 for the year ended on June 30, 2019 as against Tk 14.48 (Restated), Tk 39.28 (Restated), and Tk 6.16 (Restated) respectively for the same period in the previous year.
In 2018, the company disbursed 30 per cent cash and 10 per cent stock dividend.
Each share of the company, which was listed on the Dhaka bourse in 1989, closed at Tk 246.70 on Thursday.
The company’s paid-up capital is Tk 312.43 million and authorised capital is Tk 500 million, while the total number of securities is 31.24 million.
The sponsor-directors own 44.43 per cent stake in the company, institutional investors own 19.71 per cent and the general public 35.86 per cent as on August 31, 2019, the DSE data shows.
